Similar articles for PMID: 23763943

Year	Number of Results
1995	1
1996	1
2002	3
2003	2
2004	1
2005	4
2006	5
2007	6
2008	8
2009	8
2010	2
2011	4
2012	5
2013	9
2014	4
2015	3
2016	3
2017	5
2018	5
2019	4
2020	3
2021	3
2022	1
2023	2
2024	1

1

Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.

Elsharkawy AM, Schwab U, McCarron B, Burt AD, Daly AK, Hudson M, Masson S. Elsharkawy AM, et al. J Clin Virol. 2013 Sep;58(1):331-3. doi: 10.1016/j.jcv.2013.05.003. Epub 2013 Jun 12. J Clin Virol. 2013. PMID: 23763943

2

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study.

Yimer G, Amogne W, Habtewold A, Makonnen E, Ueda N, Suda A, Worku A, Haefeli WE, Burhenne J, Aderaye G, Lindquist L, Aklillu E. Yimer G, et al. Pharmacogenomics J. 2012 Dec;12(6):499-506. doi: 10.1038/tpj.2011.34. Epub 2011 Aug 23. Pharmacogenomics J. 2012. PMID: 21862974

3

A paediatric case of acute liver failure associated with efavirenz-based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation.

Turkova A, Ball C, Gilmour-White S, Rela M, Mieli-Vergani G. Turkova A, et al. J Antimicrob Chemother. 2009 Mar;63(3):623-5. doi: 10.1093/jac/dkn548. Epub 2009 Jan 22. J Antimicrob Chemother. 2009. PMID: 19164417 No abstract available.

4

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.

Neukam K, Mira JA, Ruiz-Morales J, Rivero A, Collado A, Torres-Cornejo A, Merino D, de Los Santos-Gil I, Macías J, González-Serrano M, Camacho A, Parra-García G, Pineda JA; SEGURIDAD HEPÁTICA Study Team of the Grupo HEPAVIR de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Neukam K, et al. J Antimicrob Chemother. 2011 Nov;66(11):2605-14. doi: 10.1093/jac/dkr357. Epub 2011 Sep 7. J Antimicrob Chemother. 2011. PMID: 21903660

5

CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.

Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Manosuthi W, et al. Int J Antimicrob Agents. 2014 Mar;43(3):292-6. doi: 10.1016/j.ijantimicag.2013.10.022. Epub 2013 Nov 25. Int J Antimicrob Agents. 2014. PMID: 24359841

6

Efavirenz intoxication due to slow hepatic metabolism.

Hasse B, Günthard HF, Bleiber G, Krause M. Hasse B, et al. Clin Infect Dis. 2005 Feb 1;40(3):e22-3. doi: 10.1086/427031. Epub 2005 Jan 7. Clin Infect Dis. 2005. PMID: 15668854

7

Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.

Lopez-Delgado JC, Mendiluce RM, Pinol TS, Fernández XP, Sanchez L, Vicente RG. Lopez-Delgado JC, et al. Ann Transplant. 2012 Jan-Mar;17(1):122-7. doi: 10.12659/aot.882645. Ann Transplant. 2012. PMID: 22466918 Review.

8

Liver transplantation for fulminant hepatitis related to nevirapine therapy.

Buyse S, Vibert E, Sebagh M, Antonini T, Ichai P, Castaing D, Samuel D, Duclos-Vallée JC. Buyse S, et al. Liver Transpl. 2006 Dec;12(12):1880-2. doi: 10.1002/lt.20985. Liver Transpl. 2006. PMID: 17133571 Free article.

9

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.

Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ. Neff GW, et al. Liver Transpl. 2003 Mar;9(3):239-47. doi: 10.1053/jlts.2003.50054. Liver Transpl. 2003. PMID: 12619020 Free article. Clinical Trial.

10

The convergence of therapeutic drug monitoring and pharmacogenetic testing to optimize efavirenz therapy.

Cabrera Figueroa S, Fernández de Gatta M, Hernández García L, Domínguez-Gil Hurlé A, Bustos Bernal C, Sepúlveda Correa R, García Sánchez MJ. Cabrera Figueroa S, et al. Ther Drug Monit. 2010 Oct;32(5):579-85. doi: 10.1097/FTD.0b013e3181f0634c. Ther Drug Monit. 2010. PMID: 20720517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year